pharma · Asthma · Multiple Sclerosis · TEVA
Teva Pharma
Teva Pharma GmbH
Teva Pharma clinical programs — 154 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
- Employees
- 126
- Programs
- 473
- Drugs
- 447
- Patents
- 454
Teva Pharma projects
154 ClinicalTrials.gov programs sponsored by Teva Pharma.
Teva Pharma has 154 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
anle138b (TEV-56286)
Teva Pharma GmbH
Healthy Volunteers
1 trial -
bendamustine
Teva Pharma GmbH
Malignancy
1 trial -
cefprozil
Teva Pharma GmbH
Healthy
1 trial -
hGH-ViaDerm™ System (hGH or somatropin)
Teva Pharma GmbH
Growth Hormone Deficiency
1 trial -
laquinimod
Teva Pharma GmbH
Pharmacokinetics
1 trial -
lipegfilgrastim
Teva Pharma GmbH
Pharmacokinetics
1 trial -
medroxyprogesterone acetate
Teva Pharma GmbH
Healthy
1 trial -
omacetaxine mepesuccinate
Teva Pharma GmbH
Hematologic Malignancies
1 trial -
pravastatin
Teva Pharma GmbH
Healthy
2 trials -
pravastatin sodium
Teva Pharma GmbH
Healthy
1 trial
Frequently asked questions
How many clinical projects does Teva Pharma have?
154 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.